GSK and Pfizer's respiratory syncytial virus (RSV) vaccines will carry warnings that they can increase the risk of developing ...

For RSV in particular, nearly two dozen states are currently reporting high levels, according to the U.S. Centers for Disease ...

For most people RSV is like a cold, but for infants and older people it can lead to serious infections. Here's what to know.

Influenza A, COVID-19 and norovirus (stomach flu) are on the rise, according to the Centers for Disease Control and ...

Vaccines and monoclonal antibodies are reducing RSV hospitalizations, but high costs and limited access in low-income ...

Respiratory illnesses are rising in B.C., with flu and respiratory syncytial virus (RSV) cases climbing, especially among ...

Respiratory syncytial virus is the leading cause of hospitalization among U.S. infants. A vaccine, nirsevimab, can reduce the ...

For immunocompromised individuals, antibody response to respiratory syncytial virus (RSV) vaccines is heterogeneous an ...

With COVID vaccine sales in the doldrums and a respiratory syncytial virus (RSV) vaccine market in “contraction”, Moderna CEO ...

Flu and COVID-19 case counts are high and rising in most parts of the United States, according to recent data by the Centers ...

Doctor visits for RSV are at a "very high" level in Mississippi. Health officials provide warning signs of RSV to look for in children, adults ...

Across the country, RSV is on the rise, and as your kids go back to school and you go back to work, there are a few things to keep in mind.